Back
Verrica Pharmaceuticals Stock Predictions
Sponsored
VRCA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
VRCA
Verrica Pharmaceuticals
Last Price:
1.00
Seasonality Move:
50.53%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Verrica Pharmaceuticals Stock Forecast
-
Is Verrica Pharmaceuticals Stock Undervalued?
The current Verrica Pharmaceuticals [VRCA] share price is $0.99. The Score for VRCA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal. - VRCA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Verrica Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Verrica Pharmaceuticals Stock Rating
Data Unavailable
Verrica Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
verrica.com
52-Week Data
52-Week High:
11.41
52-Week Low:
0.70
Prediction Charts
Market Cap:
45.35M
Price in USD:
0.99
Volume:
552.64K
Beta:
1.94
Technical Analysis
SMA50:
1.36
SMA100:
3.19
SMA200:
5.01
52-Wk Change:
-72.75%
Stock Predictions
-
Is Verrica Pharmaceuticals stock public?
Yes, Verrica Pharmaceuticals is a publicly traded company. -
What is the Verrica Pharmaceuticals stock quote today?
The Verrica Pharmaceuticals stock price is 0.99 USD today. -
How to buy Verrica Pharmaceuticals stock online?
You can buy Verrica Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-5 | 0.93 | 0.80 | 0.94 | 0.75 |
Nov-6 | 0.84 | 0.75 | 0.87 | 0.74 |
Nov-7 | 0.75 | 0.70 | 0.77 | 0.70 |
Nov-8 | 0.72 | 0.83 | 0.83 | 0.71 |
Nov-11 | 0.83 | 0.96 | 0.98 | 0.83 |
Nov-12 | 0.99 | 0.93 | 1.00 | 0.87 |
Nov-13 | 0.91 | 0.84 | 0.93 | 0.83 |
Nov-14 | 0.86 | 0.86 | 0.94 | 0.83 |
Nov-15 | 0.87 | 0.83 | 0.89 | 0.79 |
Nov-18 | 0.84 | 0.89 | 0.89 | 0.81 |
Nov-19 | 0.88 | 0.89 | 0.89 | 0.80 |
Nov-20 | 0.89 | 0.89 | 0.92 | 0.85 |
Nov-21 | 0.90 | 0.99 | 1.09 | 0.85 |
Nov-22 | 0.98 | 0.99 | 1.02 | 0.96 |
Verrica Pharmaceuticals Earnings
Data Unavailable
Verrica Pharmaceuticals Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.